Biognosys Group started a new service called 'Industrialized Discovery' to make proteomics research cheaper and easier.

BRKR · Bruker Corporation

The AI's read

It gives Bruker another role in drug research beyond supplying mass spectrometers, by pairing its instruments with sample preparation and analysis tools. The service could make those instruments part of larger research projects. The story reports no sales or customer use yet, so the business benefit remains unproven.